7 December 2016
Byotrol plc
("Byotrol" or the "Company")
Notice of Interim Results
The Company announces that it will be releasing its interim results for the six months ended 30 September 2016 on Tuesday 13 December 2016.
Enquiries:
Byotrol plc |
01925 742 000 |
David Traynor - Chief Executive
|
|
finnCap Ltd |
020 7220 0500 |
(Nominated Adviser & Broker) |
|
Geoff Nash/Carl Holmes/James Thompson - Corporate Finance |
|
Mia Gardner - Corporate Broking |
|
|
|
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist in developing, formulating and commercialising cutting-edge antimicrobial technologies.
Our patented suite of technologies delivers powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.
For more information, please go to www.byotrol.co.uk